Tela Bio Inc. (TELA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tela Bio Inc. (TELA:NASDAQ), powered by AI.

Current Price
$0.90
Sector
Healthcare
What is the Tela Bio Inc. stock price forecast?

Tela Bio Inc. is currently trading at $0.90. View real-time AI analysis on Alpha Lenz.

What is Tela Bio Inc. insider trading activity?

View the latest insider trading data for Tela Bio Inc. on Alpha Lenz.

What is Tela Bio Inc.'s P/E ratio?

View Tela Bio Inc.'s valuation metrics on Alpha Lenz.

Tela Bio Inc.

NASDAQ · TELA
$0.90+0.10(+12.17%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Tela Bio Inc.'s future dividend policy...
Alpha Chat Insight

Tela Bio Inc.'s ROE is -223.4%. Explore profitability and growth together.

Ask for details

Company Overview

Tela Bio Inc. is a company specialized in the development and commercialization of innovative soft tissue reconstruction solutions. The company's primary focus is on providing advanced medical products designed to improve the performance of soft tissue repair options, particularly in the fields of general surgery and hernia repair. Tela Bio Inc.'s portfolio includes its proprietary OviTex and OviTex PRS product lines, which incorporate biologic and synthetic materials to offer better performance and clinical outcomes compared to traditional materials. In the healthcare sector, Tela Bio operates at the intersection of biotechnology and medical devices, addressing the critical needs of surgeons and patients for more efficient and reliable surgical repairs. Tela Bio's innovative solutions are contributing to enhanced patient care, offering reduced complications and better integration with the body’s natural tissue. Headquartered in the United States, the company plays a significant role in the medical field by pushing the boundaries of soft tissue reconstruction technologies, which are vital for enhancing surgical techniques and outcomes.

CEOMr. Antony Koblish
SectorHealthcare
IndustryMedical Devices
Employees209

Company Statistics

FY 2025

Profile

N/AMarket Cap
$80.28MRevenue
0.00Shares Out
209Employees

Margins

67.69%Gross
-39.19%EBITDA
-42.05%Operating
-48.09%Pre-Tax
-48.37%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

24.68%Rev 3Yr
34.54%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-46.23%ROA
-223.35%ROE
-39.71%ROIC

Financial Health

$50.84MCash & Cash Equivalents
$24.26MNet Debt
1189.69%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tela Bio Inc. (ticker: TELA) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 209 employees.

The current price is $0.897 with a P/E ratio of -x and P/B of -x.

ROE is -223.35% and operating margin is -42.05%. Annual revenue is $80M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tela Bio Inc. (TELA) Stock Forecast 2026 $0.90 — Price, Financials & Analyst Targets | Alpha Lenz